Applied BioCode Announces Distribution Agreement with Henry Schein

SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)– #ClinicalDiagnostics–Applied BioCode today announced a distribution agreement with Henry Schein, a leading provider of healthcare products and services, to expand the availability of its BioCode® MDx-3000 System and comprehensive molecular diagnostics menu. The BioCode® MDx-3000 is an automated, high-throughput multiplex molecular diagnostic platform designed to…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks